Revenue segments as reported by the company.

Products

Premiums

Services

Net investment income

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Benefit costs

Operating expenses

Goodwill impairment

Store impairments

Opioid litigation charges

Loss on assets held for sale

Restructuring charge

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

CVS Health

Aetna is an American managed health care company, which sells traditional and consumer directed health care insurance plans and related services, such as medical, pharmaceutical, dental, behavioral health, long-term care, and disability plans. Aetna is a member of the Fortune 500.

Aetna

CVS Pharmacy is a subsidiary of the American retail and health care company CVS Health, headquartered in Woonsocket, Rhode Island. It was also known as, and originally named the Consumer Value Store and was founded in Lowell, Massachusetts, in 1963. The chain was owned by its original holding company Melville Corporation since its inception until its current parent company CVS Health was spun off into its own company in 1996. CVS Pharmacy is currently the largest pharmacy chain in the United States by number of locations (over 9,600 as of 2016) and total prescription revenue. As the retail pharmacy division of CVS Health, it ranks as the 7th largest U.S. corporation according to Fortune 500 in 2016. CVS Pharmacy's leading competitor Walgreens Boots Alliance ranked 37th.

CVS Pharmacy

CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations. The Corporate and Other Segment is involved in management and administrative expenses. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

CVS Health exceeds Q4 expectations, eyes growth with Oak Street

CVS Health's strong financial performance in 2022, driven by revenue growth and exceeding EPS expectations, positions the company well for future growth.
The acquisition of Oak Street Health presents opportunities to expand into primary care and improve long-term earnings growth, despite challenges in maintaining retail performance.

CVS Health excels in Q1, eyes growth through acquisitions and innovation

CVS Health's strong financial performance, strategic acquisitions, and customer-centric initiatives position the company for sustained growth and competitive advantage.
While facing challenges in the evolving healthcare landscape, CVS Health's focus on innovation, affordability, and operational efficiency provides a solid foundation for future success.
By capitalizing on opportunities in growth, synergies, and healthcare services, CVS Health can navigate industry headwinds and drive long-term value creation for stakeholders.

CVS Health reports robust Q2 earnings, eyes growth opportunities

CVS Health's Q2 2023 performance reflects strong financial results and strategic acquisitions driving growth.
Despite challenges like higher costs and restructuring charges, the company remains confident in its ability to deliver outstanding performance.
Opportunities lie in expanding Medicaid contracts, biosimilar market establishment, and clinic openings for at-risk populations.
Overall, CVS Health's focus on cost optimization, digital sales growth, and patient engagement positions it well for future success.

CVS Health reports robust Q3 earnings and strategic growth plans

CVS Health's Q3 performance reflects strong financial results and strategic initiatives across its segments, positioning the company for sustainable growth.
While facing challenges like declining vaccine demand and contract losses, CVS Health is focused on leveraging opportunities in biosimilars and cost-saving solutions.
The company's commitment to operational excellence, innovation, and workforce investment underscores its strategic vision for becoming a leading health solutions provider.
With a clear focus on growth drivers and mitigating challenges, CVS Health is poised to capitalize on market opportunities and deliver value to shareholders.

CVS Health reports robust Q4 earnings, eyes Medicare margin recovery

CVS Health's Q4 2023 earnings call highlighted strong financial performance, a cautious stance on Medicare Advantage utilization, and a focus on transforming healthcare delivery. The company is committed to margin recovery, growth, and enhancing customer experience while addressing challenges in Medicare Advantage trends and cost pressures.

CVS Health faces Medicare Advantage challenges, focuses on margin improvement

CVS Health's Q1 2024 earnings call highlighted strong financial performance, challenges in the Medicare Advantage business, and a focus on improving margins. The company showcased strengths in the biosimilar market and Pharmacy & Consumer Wellness segment while addressing issues impacting Health Care Benefits and Services segments.

CVS Health's Q2 2024 performance reflects strong financial results, cost savings, and innovative initiatives in pharmacy services.
The company faces challenges in the Health Care Benefits segment but is actively addressing them through leadership changes and operational improvements.
Opportunities for growth include driving margin improvements, expanding digital reach, and educating stakeholders on the value delivery of PBMs.
Expectation of margin recovery in Medicare Advantage and double-digit EPS growth in 2025 highlight CVS Health's strategic focus on operational efficiencies and cost savings.

CVS Health reports robust Q3 earnings, focuses on growth strategies

CVS Health's Q3 2024 performance was marked by strong financial results, leadership changes, and segment-specific challenges and successes. The company is focused on leveraging opportunities in strategic initiatives and addressing areas for improvement to drive future growth.

Revenue

Cost of revenue

Gross profit

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

BlackBerry

Beyond Meat

GrubHub

GrubHub, BlackBerry, CVS Health, Sprint and Beyond Meat are our must-see stock charts going into Wednesday.

5 Must-See Stock Charts for Wednesday

The fundamentals supporting CVS stock aren't great, but they will get better, meaning today's depressed valuation won't hang around forever.
The post CVS Stock Remains Too Cheap to Ignore appeared first on InvestorPlace.

CVS Stock Remains Too Cheap to Ignore

The pharmacy chain hopes the ability to get personalized health advice from in-store experts will bring more customers through its doors.

Will HealthHUBs Help CVS Survive the Retail Apocalypse?

A federal judge appears to be nearing a surprise move to block CVS’ $69 billion acquisition of Aetna, according to sources close to the health-industry giants. US District Richard Leon — who warned lawyers at a little-noticed hearing last week that they may want to cancel their summer vacation plans — looks like he is.

Fed judge nears nixing $69B CVS-Aetna deal: sources

Franklin Resources

Coca-Cola

Annaly Capital

When dividends get cut, stocks get crushed.

The Next Blue Chip Dividend To Cut Is.

Citrix Systems

Methanex

Pentair

Simon Property Group

Urban Outfitters

Wolverine World Wide

The S&P 500 is up 13.4% year to date, including dividends, leaving investors with fewer value stocks to buy.
The post 7 Stocks to Buy As They Hit 52-Week Lows appeared first on InvestorPlace.

7 Stocks to Buy As They Hit 52-Week Lows

Despite its lackluster performance in the markets, CVS stock has underappreciated moats in its health care business.
The post 3 Reasons Why Patience On CVS Health Stock Could Pay Off For Investors appeared first on InvestorPlace.

3 Reasons Why Patience On CVS Health Stock Could Pay Off For Investors

CVS Health Corp (NYSE: CVS) laid out its ideas for growing earnings growth from the low single digits expected next year, giving analysts a look at a plan that includes a turnaround in its retail long-term care business, growth at its acquired health insurer Aetna and faster-than-expected ramp up of HealthHUB stores.

CVS Turnaround Plan May Be 'Good Enough,' But Timeline Is The Question

CVS (CVS) stock jumped over 2% upon opening Tuesday morning and ended the day at $54.62, a 2.3% gain on the day. Confidence in the company?

Buy CVS Health (CVS) Stock After Optimistic Investor Day 2019?

Investor day gave investors more than a few reasons to smile.

Things CVS Health Wants You to Know About Its Future

CVS Health stock is down 22% this year; Does that, alone, make CVS a buy? Here's a look at some of the pros and cons for CVS stock.

Time to Buy Beat-Down CVS Health Stock? Here Are 3 Pros And 3 Cons

CVS Health held its investor day today, sharing plans for how it will use its acquisition of Aetna to change the landscape of healthcare, and investors liked what they heard, sending shares up 2.3%.

CVS outlines rapid expansion of in-store clinics

CVS HealthHUB stores -- which offer medical help -- are on the horizon as 1,500 of the company's locations will have these by the year 2021.
The post CVS HealthHUB Stores Coming to 1,500 CVS Locations by 2021 appeared first on InvestorPlace.

CVS HealthHUB Stores Coming to 1,500 CVS Locations by 2021

CVS Health signaled it may close more stores, even as it redesigns some of its locations to focus more on health services Tuesday at the company's investor day.

CVS to close some unprofitable stores as pharmacy chain looks to expand new HealthHUBs

CVS shares moved higher during Tuesday's session after management outlined its growth plans at its Investor Day event.

CVS Rebounds From Support as It Outlines Growth Plans

Shares of CVS Health Corp. (NYSE: CVS) popped nearly 4% Tuesday morning following the company’s announced strategy to drive growth now that the merger with Aetna is (almost) in the books.

CVS Stock Gets a Boost as Final Judicial Review on Aetna Merger Begins

CVS is making some great moves to win the healthcare war. But will it be enough to boost CVS stock over the long haul?

Can the CVS Shift to a Total Healthcare Company Really Work?

CVS Health tried to allay investor concerns Tuesday over its $70 billion acquisition of health insurer Aetna last year, projecting double-digit growth after the two companies are fully integrated in a few years.

CVS Health promises double-digit earnings growth by 2022 as it tries to allay investor worries

CVS Health Corp. said Tuesday it expects integration of health insurer Aetna will drive synergies of $300 million to $350 million in 2019, followed by about $800 million in 2020.

CVS outlines expected synergies from Aetna deal, reaffirms guidance

CVS Health Corp said it will offer expanded health services such as nutrition counseling and blood pressure screenings in 1,500 stores by the end of 2021, following through on plans announced during the pharmacy chain's 2018 acquisition of health insurer Aetna.

CVS to expand health hubs to 1,500 stores by end of 2021

CVS says it will open 1,500 HealthHUB stores by the end of 2021, focusing more on health services and products and less on candy and greeting cards.

CVS to open 1,500 HealthHUB stores over next two years

Bristol-Myers

ConocoPhillips

Wells Fargo

According to GuruFocus’ list of 52-week lows, these Guru stocks have reached their 52-week lows.

These Guru stocks have reached their 52-week lows

Designer Brands

Rite Aid

Ulta Beauty

Walgreens

Cannabidiol sales could tally $22 billion by 2022, and these brand-name companies want their piece of the pie.

9 Major Retailers That Are Selling CBD Products

CVS Health (CVS) reported earnings 30 days ago. What's next for the stock?

CVS Health (CVS) Down 7% Since Last Earnings Report: Can It Rebound?

General Electric

Block

With markets flashing weakness across the board, the number of stocks to sell is multiplying. Here are three of the most vulnerable.

News for CVS Health Stock (CVS)